ENTPD1, IL17A, and P2RX7 were downregulated, while HSP90AA1, PIK3CA, and NT5E were upregulated, indicating that ENTPD1, IL17A, and P2RX7 might negatively affect tumor development and result in better outcome. Here, IL17A is linked to neoplasm.